Read + Share
Saxena K, Herbrich SM, Pemmaraju N, Kadia TM, et al. A phase 1b/2 study of azacitidine with PD-L1 antibody avelumab in
relapsed/refractory acute myeloid leukemia. Cancer 2021 Jun 25. doi: 10.1002/cncr.33690.
PMID: 34171128
|
 |
|
Saxena K, Herbrich SM, Pemmaraju N, Kadia TM, et al. A phase 1b/2 study of azacitidine with PD-L1 antibody avelumab in
relapsed/refractory acute myeloid leukemia. Cancer 2021 Jun 25. doi: 10.1002/cncr.33690.
PMID: 34171128
|
|
|
|